|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69.30 CHF | -1.70% |
|
-6.22% | -34.13% |
| 01:25am | Cosmo Pharmaceuticals Flags Launch of Acne Treatment in Key Markets Across Europe | MT |
| 06-09 | Berenberg Reiterates Cosmo Pharmaceuticals' Buy Rating on Partnership Potential | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- COPN Stock
- Consensus Cosmo N.V.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
